Keith Regnante

Affiliations

  • Chief Financial Officer at Keros Therapeutics Inc. (KROS), 2025-02-19
  • Chief Financial Officer at Wave Life Sciences Ltd. (WVE), 2019-03-11
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
KROS $45.29 40,000 $1,811,600.00 0 2024-01-04 Filing
KROS $45.29 40,000 $1,811,600.00 0 2023-11-04 Filing
KROS $47.25 2,579 $121,857.75 0 2023-06-09 Filing
KROS $46.46 1,428 $66,344.88 2,579 2023-06-09 Filing
KROS $45.03 15,993 $720,164.79 4,007 2023-06-09 Filing